ES8800950A1 - Un metodo para preparar nuevos derivados de cefem - Google Patents
Un metodo para preparar nuevos derivados de cefemInfo
- Publication number
- ES8800950A1 ES8800950A1 ES557129A ES557129A ES8800950A1 ES 8800950 A1 ES8800950 A1 ES 8800950A1 ES 557129 A ES557129 A ES 557129A ES 557129 A ES557129 A ES 557129A ES 8800950 A1 ES8800950 A1 ES 8800950A1
- Authority
- ES
- Spain
- Prior art keywords
- group
- stands
- hydrogen atom
- compound
- antibacterial compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Superconductors And Manufacturing Methods Therefor (AREA)
Abstract
METODO PARA LA PREPARACION DE DERIVADOS DE CEFEM, DE FORMULA GENERAL (I), Y SUS SALES ESTERES FISIOLOGICA O FARMACEUTICAMENTE ACEPTABLES. CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA GENERAL (II), EN LA QUE X REPRESENTA UN ATOMO DE HALOGENO; R1 REPRESENTA UN GRUPO AMINO OPCIONALMENTE PROTEGIDO; R2 REPRESENTA UN ATOMO DE HIDROGENO, UN ATOMO DE HALOGENO O UN GRUPO NITRO; R3 REPRESENTA UN ATOMO DE HIDROGENO O UN RESTO HIDROCARBONADO OPCIONALMENTE SUSTITUIDO; R4 REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO METOXI; Y A REPRESENTA UN GRUPO IMIDAZOL-1-ILO O UNA SAL O UN ESTER DEL MISMO, CON UN COMPUESTO DE FORMULA GENERAL: R1C(FS)NH2, EN LA QUE R1 REPRESENTA UN GRUPO AMINO OPCIONALMENTE PROTEGIDO. DE APLICACION EN LA PREPARACION DE ANTIBIOTICOS.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP1984/000212 WO1985004879A1 (fr) | 1984-04-23 | 1984-04-23 | Nouveaux composes de cephem |
PCT/JP1984/000270 WO1985005620A1 (en) | 1984-05-25 | 1984-05-25 | Cephem compounds |
PCT/JP1985/000102 WO1986005184A1 (en) | 1985-03-01 | 1985-03-01 | Antibacterial compound |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8800950A1 true ES8800950A1 (es) | 1987-12-01 |
ES557129A0 ES557129A0 (es) | 1987-12-01 |
Family
ID=27304399
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES542447A Expired ES8606362A1 (es) | 1984-04-23 | 1985-04-22 | "un procedimiento para preparar un derivado de cefem". |
ES549180A Expired ES8707245A1 (es) | 1984-04-23 | 1985-11-22 | Un metodo para preparar nuevos derivados de cefem |
ES553666A Expired ES8706692A1 (es) | 1984-04-23 | 1986-04-03 | Un metodo para preparar nuevos derivados de cefem |
ES557129A Expired ES8800950A1 (es) | 1984-04-23 | 1986-10-03 | Un metodo para preparar nuevos derivados de cefem |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES542447A Expired ES8606362A1 (es) | 1984-04-23 | 1985-04-22 | "un procedimiento para preparar un derivado de cefem". |
ES549180A Expired ES8707245A1 (es) | 1984-04-23 | 1985-11-22 | Un metodo para preparar nuevos derivados de cefem |
ES553666A Expired ES8706692A1 (es) | 1984-04-23 | 1986-04-03 | Un metodo para preparar nuevos derivados de cefem |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0160252B1 (es) |
JP (1) | JPH07103130B2 (es) |
KR (2) | KR920008945B1 (es) |
AU (1) | AU580995B2 (es) |
CA (1) | CA1283096C (es) |
DE (2) | DE3586547D1 (es) |
ES (4) | ES8606362A1 (es) |
FI (1) | FI851592L (es) |
GR (1) | GR850965B (es) |
NO (2) | NO165842C (es) |
NZ (1) | NZ211858A (es) |
PH (1) | PH23134A (es) |
PT (1) | PT80328B (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH22107A (en) * | 1984-06-07 | 1988-06-01 | Takeda Chemical Industries Ltd | 3-pyrazolo(1,5-a)pyrdinium cephem compounds |
NO166283C (no) * | 1985-03-01 | 1991-06-26 | Takeda Chemical Industries Ltd | Analogifremgangsmaate for fremstilling av terapeutisk aktive 7beta-(2-(5-amino-1,2,4-tiadiazol-3-yl)-2(z)-substituertoksyiminoacetamido)-3-(heterocyclylmetyl)-3-cefem-4-karboksylsyrederivater. |
ATE89826T1 (de) * | 1985-03-01 | 1993-06-15 | Takeda Chemical Industries Ltd | Antibakterielle verbindungen, ihre herstellung und verwendung. |
JP2519054B2 (ja) * | 1986-06-09 | 1996-07-31 | 武田薬品工業株式会社 | 新規セフェム化合物 |
US4921851A (en) * | 1986-06-09 | 1990-05-01 | Takeda Chemical Industries, Ltd. | Cephem compounds, their production and use |
DE3707019A1 (de) * | 1987-03-05 | 1988-09-15 | Hoechst Ag | Cephalosporinderivate und verfahren zu ihrer herstellung |
AU615966B2 (en) * | 1987-12-04 | 1991-10-17 | Takeda Chemical Industries Ltd. | Crystals of cephem hydrochloride |
US4933334A (en) * | 1987-12-04 | 1990-06-12 | Takeda Chemical Industries, Ltd. | Antibiotic composition |
ATE117690T1 (de) * | 1990-03-01 | 1995-02-15 | Takeda Chemical Industries Ltd | Imidazopyridazine, ihre herstellung und verwendung. |
TW526202B (en) | 1998-11-27 | 2003-04-01 | Shionogi & Amp Co | Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity |
JP2006525340A (ja) * | 2003-04-30 | 2006-11-09 | トライン・ファーマシューティカルズ・インコーポレイテッド | カルバセフェムβ−ラクタム系抗生物質 |
US9238657B2 (en) | 2008-10-31 | 2016-01-19 | Shionogi & Co., Ltd. | Cephalosporin having catechol group |
RU2012146986A (ru) | 2010-04-05 | 2014-05-20 | Сионоги Энд Ко., Лтд. | Цефемовые соединения, содержащие катехольную группу |
TWI547496B (zh) | 2011-10-04 | 2016-09-01 | 葛蘭素集團公司 | 抗菌化合物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4165430A (en) * | 1976-03-19 | 1979-08-21 | Glaxo Laboratories Limited | Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group |
EP0062321B1 (en) * | 1981-04-03 | 1989-03-01 | Fujisawa Pharmaceutical Co., Ltd. | New cephem compounds, processes for their preparation, pharmaceutical compositions containing them and their starting compounds |
DE3336757A1 (de) * | 1983-10-08 | 1985-04-25 | Hoechst Ag, 6230 Frankfurt | Cephalosporinderivate und verfahren zu ihrer herstellung |
-
1985
- 1985-04-17 NO NO851538A patent/NO165842C/no unknown
- 1985-04-18 DE DE8585104687A patent/DE3586547D1/de not_active Expired - Fee Related
- 1985-04-18 PH PH32153A patent/PH23134A/en unknown
- 1985-04-18 EP EP85104687A patent/EP0160252B1/en not_active Expired - Lifetime
- 1985-04-18 DE DE8585104687T patent/DE3586547T2/de not_active Expired - Lifetime
- 1985-04-22 JP JP60086746A patent/JPH07103130B2/ja not_active Expired - Fee Related
- 1985-04-22 FI FI851592A patent/FI851592L/fi not_active Application Discontinuation
- 1985-04-22 ES ES542447A patent/ES8606362A1/es not_active Expired
- 1985-04-22 PT PT80328A patent/PT80328B/pt not_active IP Right Cessation
- 1985-04-22 NZ NZ211858A patent/NZ211858A/xx unknown
- 1985-04-22 GR GR850965A patent/GR850965B/el unknown
- 1985-04-23 KR KR1019850002737A patent/KR920008945B1/ko not_active IP Right Cessation
- 1985-04-23 AU AU41700/85A patent/AU580995B2/en not_active Ceased
- 1985-04-23 CA CA000479769A patent/CA1283096C/en not_active Expired - Lifetime
- 1985-11-22 ES ES549180A patent/ES8707245A1/es not_active Expired
- 1985-11-26 NO NO85854730A patent/NO167293C/no unknown
-
1986
- 1986-04-03 ES ES553666A patent/ES8706692A1/es not_active Expired
- 1986-10-03 ES ES557129A patent/ES8800950A1/es not_active Expired
-
1991
- 1991-11-16 KR KR1019910020376A patent/KR920008953B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE3586547D1 (de) | 1993-02-04 |
ES553666A0 (es) | 1987-06-16 |
DE3586547A1 (es) | 1993-02-04 |
ES8606362A1 (es) | 1986-04-01 |
NO165842C (no) | 1991-04-17 |
NO165842B (no) | 1991-01-07 |
GR850965B (es) | 1985-11-25 |
NO167293B (no) | 1991-07-15 |
ES8707245A1 (es) | 1987-07-16 |
PT80328B (en) | 1987-02-16 |
JPS60231684A (ja) | 1985-11-18 |
EP0160252B1 (en) | 1992-08-26 |
ES8706692A1 (es) | 1987-06-16 |
ES549180A0 (es) | 1987-07-16 |
PH23134A (en) | 1989-05-11 |
AU4170085A (en) | 1985-10-31 |
EP0160252A3 (en) | 1987-01-14 |
NO851538L (no) | 1985-10-24 |
AU580995B2 (en) | 1989-02-09 |
JPH07103130B2 (ja) | 1995-11-08 |
FI851592L (fi) | 1985-10-24 |
EP0160252A2 (en) | 1985-11-06 |
DE3586547T2 (de) | 1993-04-15 |
PT80328A (en) | 1985-05-01 |
ES542447A0 (es) | 1986-04-01 |
KR920008945B1 (ko) | 1992-10-12 |
NO854730L (no) | 1985-10-24 |
NO167293C (no) | 1991-10-23 |
KR850007427A (ko) | 1985-12-04 |
FI851592A0 (fi) | 1985-04-22 |
ES557129A0 (es) | 1987-12-01 |
CA1283096C (en) | 1991-04-16 |
KR920008953B1 (ko) | 1992-10-12 |
NZ211858A (en) | 1988-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE892340L (en) | 4-oxoquinoline-3-carboxylic acid derivatives, their¹preparation and their use | |
ES8800682A1 (es) | Un procedimiento para la preparacion de nuevas (4-piperidinilmetil y heteropurinas) | |
ES8706692A1 (es) | Un metodo para preparar nuevos derivados de cefem | |
ES8801290A1 (es) | Un metodo para preparar derivados de cefem | |
ES8802148A1 (es) | Procedimiento para preparar derivados de acido quinoloncarboxilico | |
ES8707541A1 (es) | Un procedimiento para la preparacion de derivados de cefalosporina | |
ES8705408A1 (es) | Un procedimiento para preparar un derivado de 1,5-benzotiazepina. | |
ES8606330A1 (es) | Procedimiento para preparar derivados de acidos quinolincar-boxilicos | |
ES8609343A1 (es) | Un metodo para preparar un derivado de cefem | |
ES8704932A1 (es) | Procedimiento para preparar un derivado de acido quinoloncarboxilico | |
ES8606283A1 (es) | Procedimiento para preparar derivados de acidos quinolon- carboxilicos | |
EP0342665A3 (en) | Physiologically active substance tan-931, its derivatives, their production and use | |
GR3030506T3 (en) | 1-azaadamantane derivatives as 5-ht agonists or antagonists. | |
AU541530B2 (en) | Derivatives of indolobenzoxazine | |
MY108303A (en) | Neuroleptic 2-substituted perhydro-1-h-pyrido [1,2-a]pyrazines. | |
US5563157B1 (en) | Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof | |
MY102089A (en) | Antibacterial compounds. | |
AU559732B2 (en) | Di-and-tetrahydroguinolylacetic acid esters | |
AU551901B2 (en) | Substituted thienobenzodiazepinones | |
AP9400608A0 (en) | "New nicotinic acid derivative". | |
HUP0001545A2 (hu) | Karbonsavészterszármazékok, előállításuk és alkalmazásuk herbicid hatású piridazin-3-on-származékok előállítására | |
AU2013888A (en) | Uricosuric composition | |
ES8704163A1 (es) | Un procedimiento para preparar derivados de cefem. | |
ES8506313A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 7-oxo-1-azabiciclo(3.2.0)hepteno. | |
ES8307812A1 (es) | Un procedimiento para la preparacion de nuevos amidin derivados del acido clavulawilo. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 19960603 |